Clinical Trials Browser

cobimetinib × Other hematologic neoplasm × 90 days × Clear all

NCT05441514 2026-05-05

Enasidenib in Combination With Cobimetinib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04409639 2026-04-24

CONCERTO

Phase 2 Active not recruiting

14 enrolled 20 charts

Other hematologic neoplasm

Leukemia, Myelomonocytic, Chronic